| Ident. | Authors (with country if any) | Title |
|---|
| 000051 (2020) |
Calvin J. Gordon [Canada] ; Egor P. Tchesnokov [Canada] ; Joy Y. Feng [États-Unis] ; Danielle P. Porter [États-Unis] ; Matthias Götte [Canada] | The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus |
| 000078 (2020) |
Mahmoud Kandeel [Arabie saoudite] ; Mizuki Yamamoto [Japon] ; Abdulla Al-Taher [Arabie saoudite] ; Aya Watanabe [Japon] ; Kentaro Oh-Hashi [Japon] ; Byoung Kwon Park [Corée du Sud] ; Hyung-Joo Kwon [Corée du Sud] ; Jun-Ichiro Inoue [Japon] ; Mohammed Al-Nazawi [Arabie saoudite] | Small Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Fusion by Targeting Cavities on Heptad Repeat Trimers. |
| 000095 (2020) |
Calvin J. Gordon [Canada] ; Egor P. Tchesnokov [Canada] ; Emma Woolner [Canada] ; Jason K. Perry [États-Unis] ; Joy Y. Feng [États-Unis] ; Danielle P. Porter [États-Unis] ; Matthias Gotte [Canada] | Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency. |
| 000157 (2020) |
Kaihao Liang | Mathematical model of infection kinetics and its analysis for COVID-19, SARS and MERS |
| 000162 (2020) |
Ying Yan [République populaire de Chine] ; Le Chang [République populaire de Chine] ; Lunan Wang [République populaire de Chine] | Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): Current status, challenges, and countermeasures. |
| 000170 (2020) |
Shuai Xia [République populaire de Chine] ; Meiqin Liu [République populaire de Chine] ; Chao Wang [République populaire de Chine] ; Wei Xu [République populaire de Chine] ; Qiaoshuai Lan [République populaire de Chine] ; Siliang Feng [République populaire de Chine] ; Feifei Qi [République populaire de Chine] ; Linlin Bao [République populaire de Chine] ; Lanying Du [États-Unis] ; Shuwen Liu [République populaire de Chine] ; Chuan Qin [République populaire de Chine] ; Fei Sun [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Yun Zhu [République populaire de Chine] ; Shibo Jiang [République populaire de Chine, États-Unis] ; Lu Lu [République populaire de Chine] | Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion |
| 000227 (2020) |
Nashwa Hafez Zaher [Égypte] ; Mohammed Ismail Mostafa [Égypte] ; Abdullah Yousef Altaher | Design, synthesis and molecular docking of novel triazole derivatives as potential CoV helicase inhibitors. |
| 000239 (2020) |
Tiffany Tang [États-Unis] ; Miya Bidon [États-Unis] ; Javier A. Jaimes [États-Unis] ; Gary R. Whittaker [États-Unis] ; Susan Daniel [États-Unis] | Coronavirus membrane fusion mechanism offers as a potential target for antiviral development. |
| 000369 (2019) |
Haixia Zhou [République populaire de Chine] ; Yingzhu Chen [République populaire de Chine] ; Shuyuan Zhang [République populaire de Chine] ; Peihua Niu [République populaire de Chine] ; Kun Qin [République populaire de Chine] ; Wenxu Jia [République populaire de Chine] ; Baoying Huang [République populaire de Chine] ; Senyan Zhang [République populaire de Chine] ; Jun Lan [République populaire de Chine] ; Linqi Zhang [République populaire de Chine] ; Wenjie Tan [République populaire de Chine] ; Xinquan Wang [République populaire de Chine] | Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein |
| 000382 (2019) |
Felix Zellmann ; Laura Thomas ; Ute Scheffer ; Roland K. Hartmann ; Michael W. Göbel | Site-Specific Cleavage of RNAs Derived from the PIM1 3′-UTR by a Metal-Free Artificial Ribonuclease |
| 000396 (2019) |
Nils C. Gassen [Allemagne] ; Daniela Niemeyer [Allemagne] ; Doreen Muth [Allemagne] ; Victor M. Corman [Allemagne] ; Silvia Martinelli [Allemagne] ; Alwine Gassen [Allemagne] ; Kathrin Hafner [Allemagne] ; Jan Papies [Allemagne] ; Kirstin Mösbauer [Allemagne] ; Andreas Zellner [Allemagne] ; Anthony S. Zannas [Allemagne, États-Unis] ; Alexander Herrmann [Allemagne] ; Florian Holsboer [Allemagne] ; Ruth Brack-Werner [Allemagne] ; Michael Boshart [Allemagne] ; Bertram Müller-Myhsok [Allemagne, Royaume-Uni] ; Christian Drosten [Allemagne] ; Marcel A. Müller [Allemagne, Russie] ; Theo Rein [Allemagne] | SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection |
| 000450 (2019) |
Hannah Kleine-Weber [Allemagne] ; Mahmoud Tarek Elzayat [Allemagne] ; Lingshu Wang [États-Unis] ; Barney S. Graham [États-Unis] ; Marcel A. Müller [Allemagne] ; Christian Drosten [Allemagne] ; Stefan Pöhlmann ; Markus Hoffmann | Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization. |
| 000471 (2019) |
Jeong Yoon Lee [Corée du Sud] ; Sojung Bae [Corée du Sud] ; Jinjong Myoung [Corée du Sud] | Middle East Respiratory Syndrome Coronavirus-Encoded Accessory Proteins Impair MDA5-and TBK1-Mediated Activation of NF-κB. |
| 000536 (2019) |
Young Sup Shin [Corée du Sud] ; Dnyandev B. Jarhad [Corée du Sud] ; Min Hwan Jang [Corée du Sud] ; Kristina Kovacikova [Pays-Bas] ; Gyudong Kim [Corée du Sud] ; Ji-Seong Yoon [Corée du Sud] ; Hong-Rae Kim [Corée du Sud] ; Young Eum Hyun [Corée du Sud] ; Amol S. Tipnis [Corée du Sud] ; Tong-Shin Chang [Corée du Sud] ; Martijn J. Van Hemert [Pays-Bas] ; Lak Shin Jeong [Corée du Sud] | Identification of 6′-β-fluoro-homoaristeromycin as a potent inhibitor of chikungunya virus replication |
| 000599 (2019) |
Lei He ; Wanbo Tai ; Jiangfan Li ; Yuehong Chen ; Yaning Gao ; Junfeng Li ; Shihui Sun ; Yusen Zhou [République populaire de Chine] ; Lanying Du ; Guangyu Zhao | Enhanced Ability of Oligomeric Nanobodies Targeting MERS Coronavirus Receptor-Binding Domain |
| 000652 (2019) |
Yuting Jiang ; Junfeng Li ; Yue Teng ; Hong Sun ; Guang Tian ; Lei He ; Pei Li ; Yuehong Chen ; Yan Guo ; Jiangfan Li ; Guangyu Zhao ; Yusen Zhou [République populaire de Chine] ; Shihui Sun | Complement Receptor C5aR1 Inhibition Reduces Pyroptosis in hDPP4-Transgenic Mice Infected with MERS-CoV |
| 000715 (2019) |
Jun Yong Choi [Corée du Sud] ; Jin Ok Oh [Corée du Sud] ; Jin Young Ahn [Corée du Sud] ; Heun Choi [Corée du Sud] ; Jung Ho Kim [Corée du Sud] ; Hye Seong [Corée du Sud] ; Su Jin Jeong [Corée du Sud] ; Nam Su Ku [Corée du Sud] ; Joon-Sup Yeom [Corée du Sud] ; Jae-Phil Choi [Corée du Sud] | Absence of neutralizing activity in serum 1 year after successful treatment with antivirals and recovery from MERS in South Korea |
| 000787 (2018) |
Keisuke Nakagawa [États-Unis] ; Krishna Narayanan [États-Unis] ; Masami Wada [États-Unis] ; Vsevolod L. Popov [États-Unis] ; Maria Cajimat [États-Unis] ; Ralph S. Baric [États-Unis] ; Shinji Makino [États-Unis] | The Endonucleolytic RNA Cleavage Function of nsp1 of Middle East Respiratory Syndrome Coronavirus Promotes the Production of Infectious Virus Particles in Specific Human Cell Lines. |
| 000855 (2018) |
Hsu-Feng Chu [Taïwan] ; Chiao-Che Chen [Taïwan] ; David C. Moses [Taïwan] ; Yau-Hung Chen [Taïwan] ; Chao-Hsiung Lin [Taïwan] ; Ying-Chieh Tsai [Taïwan] ; Chi-Yuan Chou [Taïwan] | Porcine epidemic diarrhea virus papain-like protease 2 can be noncompetitively inhibited by 6-thioguanine |
| 000896 (2018) |
Shutoku Matsuyama [Japon] ; Kazuya Shirato [Japon] ; Miyuki Kawase [Japon] ; Yutaka Terada [Japon] ; Kengo Kawachi [Japon] ; Shuetsu Fukushi [Japon] ; Wataru Kamitani [Japon] | Middle East Respiratory Syndrome Coronavirus Spike Protein Is Not Activated Directly by Cellular Furin during Viral Entry into Target Cells. |
| 000933 (2018) |
Keisuke Nakagawa [États-Unis] ; Krishna Narayanan [États-Unis] ; Masami Wada [États-Unis] ; Shinji Makino [États-Unis] | Inhibition of Stress Granule Formation by Middle East Respiratory Syndrome Coronavirus 4a Accessory Protein Facilitates Viral Translation, Leading to Efficient Virus Replication. |
